This is also sadly wrong. There are regulatory bodies overseeing only a very tiny fraction of generic prescription drug production (ask how often they inspect and test batches) because of a systemic drive to dismantle and defund regulatory oversight exactly as championed by the person I was replying to.

Oversight in the face of rampant fraud requires testing continuously, not once every few years, not sometimes after something goes wrong, and it requires funding to hire overseers.